2C-T-29

2C-T-29, also known as 2C-T-PARGY or 2C-T-PROPARGYL or as 4-propargylthio-2,5-dimethoxyphenethylamine, is a designer drug from the substituted phenethylamine family, which was first synthesised by Josh Hartsel and colleagues in 2024.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

2C-T-29, also known as 2C-T-PARGY or 2C-T-PROPARGYL or as 4-propargylthio-2,5-dimethoxyphenethylamine, is a designer drug from the substituted phenethylamine family, which was first synthesised by Josh Hartsel and colleagues in 2024. It is a potent agonist at the serotonin receptor 5-HT 2A in vitro, with a binding affinity (K i ) of 1.3 nM and an EC 50 of 0.67 nM, acting as a full agonist.

While the closely related propylthio compound 2C-T-7 and the allylthio derivative 2C-T-16 are both known to be potent psychedelic drugs in humans, the propargylthio analogue 2C-T-29 is not known to have been tested in humans or other animals. It is a controlled substance in Canada under phenethylamine blanket-ban language.

2C-T-29, also known as 2C-T-PARGY or 2C-T-PROPARGYL or as 4-propargylthio-2,5-dimethoxyphenethylamine, is a designer drug from the substituted phenethylamine family, which was first synthesised by Josh Hartsel and colleagues in 2024. It is a potent agonist at the serotonin receptor 5-HT 2A in vitro, with a binding affinity (K i ) of 1.3 nM and an EC 50 of 0.67 nM, acting as a full agonist.

While the closely related propylthio compound 2C-T-7 and the allylthio derivative 2C-T-16 are both known to be potent psychedelic drugs in humans, the propargylthio analogue 2C-T-29 is not known to have been tested in humans or other animals. It is a controlled substance in Canada under phenethylamine blanket-ban language.

2C-T-29 - Isomer Design

Text derived from https://en.wikipedia.org/w/index.php?oldid=1371212413 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.